Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Over the Counter (OTC) and Diet Supplementary market report explains the definition, types, applications, major countries, and major players of the Over the Counter (OTC) and Diet Supplementary market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Johnson & Johnson
GlaxoSmithKline
Pfizer
Allergan
Merck KGaA
Teva Pharmaceutical Industries
Novartis
Alkem Laboratories
Bayer AG
Sun Pharma
By Type:
Analgesic & pain relievers
Dermatological products
Cough, cold, and flu products
Vitamin supplements
Mineral Supplements
Ophthalmic Products
By End-User:
Hospital
Clinic
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Over the Counter (OTC) and Diet Supplementary Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Over the Counter (OTC) and Diet Supplementary Outlook to 2028- Original Forecasts
-
2.2 Over the Counter (OTC) and Diet Supplementary Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Over the Counter (OTC) and Diet Supplementary Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Over the Counter (OTC) and Diet Supplementary Market- Recent Developments
-
6.1 Over the Counter (OTC) and Diet Supplementary Market News and Developments
-
6.2 Over the Counter (OTC) and Diet Supplementary Market Deals Landscape
7 Over the Counter (OTC) and Diet Supplementary Raw Materials and Cost Structure Analysis
-
7.1 Over the Counter (OTC) and Diet Supplementary Key Raw Materials
-
7.2 Over the Counter (OTC) and Diet Supplementary Price Trend of Key Raw Materials
-
7.3 Over the Counter (OTC) and Diet Supplementary Key Suppliers of Raw Materials
-
7.4 Over the Counter (OTC) and Diet Supplementary Market Concentration Rate of Raw Materials
-
7.5 Over the Counter (OTC) and Diet Supplementary Cost Structure Analysis
-
7.5.1 Over the Counter (OTC) and Diet Supplementary Raw Materials Analysis
-
7.5.2 Over the Counter (OTC) and Diet Supplementary Labor Cost Analysis
-
7.5.3 Over the Counter (OTC) and Diet Supplementary Manufacturing Expenses Analysis
8 Global Over the Counter (OTC) and Diet Supplementary Import and Export Analysis (Top 10 Countries)
-
8.1 Global Over the Counter (OTC) and Diet Supplementary Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Over the Counter (OTC) and Diet Supplementary Export by Region (Top 10 Countries) (2017-2028)
9 Global Over the Counter (OTC) and Diet Supplementary Market Outlook by Types and Applications to 2022
-
9.1 Global Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Analgesic & pain relievers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dermatological products Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cough, cold, and flu products Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Vitamin supplements Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Mineral Supplements Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Ophthalmic Products Consumption and Growth Rate (2017-2022)
-
9.2 Global Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Over the Counter (OTC) and Diet Supplementary Market Analysis and Outlook till 2022
-
10.1 Global Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.2.2 Canada Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.2.3 Mexico Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.2 UK Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.3 Spain Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.4 Belgium Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.5 France Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.6 Italy Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.7 Denmark Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.8 Finland Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.9 Norway Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.10 Sweden Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.11 Poland Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.12 Russia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.3.13 Turkey Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.2 Japan Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.3 India Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.4 South Korea Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.5 Pakistan Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.6 Bangladesh Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.7 Indonesia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.8 Thailand Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.9 Singapore Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.10 Malaysia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.11 Philippines Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.4.12 Vietnam Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.2 Colombia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.3 Chile Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.4 Argentina Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.5 Venezuela Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.6 Peru Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.7 Puerto Rico Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.5.8 Ecuador Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6.2 Kuwait Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6.3 Oman Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6.4 Qatar Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6.5 Saudi Arabia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.6.6 United Arab Emirates Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.7.2 South Africa Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.7.3 Egypt Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.7.4 Algeria Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
-
10.8.2 New Zealand Over the Counter (OTC) and Diet Supplementary Consumption (2017-2022)
11 Global Over the Counter (OTC) and Diet Supplementary Competitive Analysis
-
11.1 Johnson & Johnson
-
11.1.1 Johnson & Johnson Company Details
-
11.1.2 Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.1.4 Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Company Details
-
11.2.2 GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.2.4 GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer
-
11.3.1 Pfizer Company Details
-
11.3.2 Pfizer Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.3.4 Pfizer Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Allergan
-
11.4.1 Allergan Company Details
-
11.4.2 Allergan Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Allergan Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.4.4 Allergan Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Merck KGaA
-
11.5.1 Merck KGaA Company Details
-
11.5.2 Merck KGaA Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Merck KGaA Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.5.4 Merck KGaA Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Teva Pharmaceutical Industries
-
11.6.1 Teva Pharmaceutical Industries Company Details
-
11.6.2 Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.6.4 Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Novartis
-
11.7.1 Novartis Company Details
-
11.7.2 Novartis Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Novartis Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.7.4 Novartis Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Alkem Laboratories
-
11.8.1 Alkem Laboratories Company Details
-
11.8.2 Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.8.4 Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bayer AG
-
11.9.1 Bayer AG Company Details
-
11.9.2 Bayer AG Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bayer AG Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.9.4 Bayer AG Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Sun Pharma
-
11.10.1 Sun Pharma Company Details
-
11.10.2 Sun Pharma Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Sun Pharma Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
11.10.4 Sun Pharma Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Over the Counter (OTC) and Diet Supplementary Market Outlook by Types and Applications to 2028
-
12.1 Global Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Analgesic & pain relievers Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Dermatological products Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Cough, cold, and flu products Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Vitamin supplements Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Mineral Supplements Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Over the Counter (OTC) and Diet Supplementary Market Analysis and Outlook to 2028
-
13.1 Global Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.2.2 Canada Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.2.3 Mexico Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.2 UK Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.3 Spain Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.4 Belgium Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.5 France Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.6 Italy Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.7 Denmark Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.8 Finland Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.9 Norway Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.10 Sweden Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.11 Poland Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.12 Russia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.3.13 Turkey Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.2 Japan Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.3 India Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.4 South Korea Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.8 Thailand Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.9 Singapore Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.11 Philippines Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.2 Colombia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.3 Chile Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.4 Argentina Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.6 Peru Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6.3 Oman Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6.4 Qatar Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.7.2 South Africa Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.7.3 Egypt Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.7.4 Algeria Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Over the Counter (OTC) and Diet Supplementary Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Over the Counter (OTC) and Diet Supplementary
-
Figure of Over the Counter (OTC) and Diet Supplementary Picture
-
Table Global Over the Counter (OTC) and Diet Supplementary Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Over the Counter (OTC) and Diet Supplementary Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Analgesic & pain relievers Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatological products Consumption and Growth Rate (2017-2022)
-
Figure Global Cough, cold, and flu products Consumption and Growth Rate (2017-2022)
-
Figure Global Vitamin supplements Consumption and Growth Rate (2017-2022)
-
Figure Global Mineral Supplements Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmic Products Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Table North America Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure United States Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Canada Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Mexico Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table Europe Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure Germany Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure UK Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Spain Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Belgium Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure France Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Italy Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Denmark Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Finland Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Norway Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Sweden Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Poland Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Russia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Turkey Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table APAC Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure China Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Japan Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure India Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure South Korea Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Thailand Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Singapore Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Philippines Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table South America Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure Brazil Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Colombia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Chile Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Argentina Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Peru Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table GCC Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure Bahrain Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Oman Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Qatar Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table Africa Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure Nigeria Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure South Africa Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Egypt Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure Algeria Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table Oceania Over the Counter (OTC) and Diet Supplementary Consumption by Country (2017-2022)
-
Figure Australia Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Over the Counter (OTC) and Diet Supplementary Consumption and Growth Rate (2017-2022)
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Johnson & Johnson Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table GlaxoSmithKline Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Pfizer Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Allergan Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Merck KGaA Company Details
-
Table Merck KGaA Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Merck KGaA Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Teva Pharmaceutical Industries Company Details
-
Table Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Teva Pharmaceutical Industries Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Novartis Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Alkem Laboratories Company Details
-
Table Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Alkem Laboratories Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Bayer AG Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Table Sun Pharma Company Details
-
Table Sun Pharma Over the Counter (OTC) and Diet Supplementary Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Over the Counter (OTC) and Diet Supplementary Main Business and Markets Served
-
Table Sun Pharma Over the Counter (OTC) and Diet Supplementary Product Portfolio
-
Figure Global Analgesic & pain relievers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatological products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cough, cold, and flu products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vitamin supplements Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mineral Supplements Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Table North America Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure United States Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure Germany Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure China Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure Brazil Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Over the Counter (OTC) and Diet Supplementary Consumption Forecast by Country (2022-2028)
-
Figure Australia Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Over the Counter (OTC) and Diet Supplementary Consumption Forecast and Growth Rate (2022-2028)
-
